{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:02:38Z","timestamp":1761843758832},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T00:00:00Z","timestamp":1201651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Essential Thrombocythcythaemia (ET) is an uncommon type of myeloproliferative disorder, characterised by both thrombotic and haemorrhagic diathesis. No clear guidelines exist for the pre- and post-operative management of patients undergoing cardiac surgery in the haematological and surgical literature. This condition has profound implications in patients undergoing cardiac surgery with the use of cardiopulmonary bypass, where heparin is used for anti-coagulation. This dilemma is further compounded in the setting of a young patient undergoing aortic valve replacement (AVR), where insertion of a mechanical prosthesis would be the procedure of choice. This would require life-long anticoagulation with warfarin which can predispose these patients to catastrophic bleeding. Using a tissue valve will subject the patient to multiple redo operations in the patient's lifetime. We report a young patient with ET requiring AVR and discuss the dilemmas surrounding the choice of prosthesis in this patient.<\/jats:p>","DOI":"10.1186\/1749-8090-3-5","type":"journal-article","created":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T19:14:31Z","timestamp":1201720471000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Aortic valve replacement in a young patient with essential thrombocytosis"],"prefix":"10.1186","volume":"3","author":[{"given":"Kashif","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunaid A","family":"Vohra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Milne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M","family":"Langley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,30]]},"reference":[{"key":"105_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/BF01891529","volume":"292","author":"E Epstein","year":"1934","unstructured":"Epstein E, Goedel A: Hammorhagische thrombocythamie bei vascularer schrumpfmilz. Virch Arch (Pathol Anat). 1934, 292: 233-10.1007\/BF01891529.","journal-title":"Virch Arch (Pathol Anat)"},{"issue":"1","key":"105_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2141.1993.tb04624.x","volume":"83","author":"G Zauli","year":"1993","unstructured":"Zauli G, Visani G, Catani L: Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor beta 1, produced in normal amount, in patients with essential thrombocythaemia. Br J Haematol. 1993, 83 (1): 14-20.","journal-title":"Br J Haematol"},{"issue":"2","key":"105_CR3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood.V93.2.417","volume":"93","author":"CN Harrison","year":"1999","unstructured":"Harrison CN, Gale RE, Machin SJ: A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. Blood. 1999, 93 (2): 417-24.","journal-title":"Blood"},{"key":"105_CR4","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0003-4975(99)00068-5","volume":"67","author":"FD Rubens","year":"1999","unstructured":"Rubens FD, Labow RS, Lavall\u00e9e GR, Watson MI, Robblee JA, Voorhees ME, Nathan HJ: Hematologic evaluation of cardiopulmonary bypass circuits prepared with a novel block copolymer. Ann Thorac Surg. 1999, 67: 696-10.1016\/S0003-4975(99)00068-5.","journal-title":"Ann Thorac Surg"},{"key":"105_CR5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0022-5223(19)34036-X","volume":"106","author":"N Tabuchi","year":"1993","unstructured":"Tabuchi N, Haan J, Boonstra PW, van Oeveren W: Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993, 106: 828","journal-title":"J Thorac Cardiovasc Surg"},{"key":"105_CR6","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1056\/NEJM199506083322306","volume":"332","author":"J Lefkovits","year":"1995","unstructured":"Lefkovits J, Plow EF, Topol EJ: Platelet glycoprotein Iib\/IIIa receptors in cardiovascular medicine. N Engl J Med. 1995, 332: 1553-10.1056\/NEJM199506083322306.","journal-title":"N Engl J Med"},{"key":"105_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1172\/JCI112582","volume":"78","author":"JN George","year":"1986","unstructured":"George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ: Platelet surface glycoproteins; studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest. 1986, 78: 340","journal-title":"J Clin Invest"},{"issue":"2","key":"105_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF01698487","volume":"69","author":"PJ van Genderen","year":"1994","unstructured":"van Genderen PJ, Michiels JJ, van der Poel-van de Luytgaarde SC: Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count. Ann Hematol. 1994, 69 (2): 81-4. 10.1007\/BF01698487.","journal-title":"Ann Hematol"},{"issue":"4","key":"105_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0049-3848(03)00182-8","volume":"109","author":"JF Bradfield","year":"2003","unstructured":"Bradfield JF, Bode AP: Aprotinin restores the adhesive capacity of dysfunctional platelets. Thromb Res. 2003, 109 (4): 181-8. 10.1016\/S0049-3848(03)00182-8.","journal-title":"Thromb Res"},{"issue":"9 Suppl","key":"105_CR10","first-page":"I276","volume":"112","author":"J van der Linden","year":"2005","unstructured":"van der Linden J, Lindvall G, Sartipy U: Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. Circulation. 2005, 112 (9 Suppl): I276-80.","journal-title":"Circulation"},{"issue":"3","key":"105_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000204873","volume":"85","author":"F Cervantes","year":"1991","unstructured":"Cervantes F, Tassies D, Salgado C: Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients. Acta Haematol. 1991, 85 (3): 124-7.","journal-title":"Acta Haematol"},{"issue":"2","key":"105_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s002770000244","volume":"80","author":"R Jantunen","year":"2001","unstructured":"Jantunen R, Juvonen E, Ikkala E: The predictive value of vascular risk factors and gender for the development of thrombotic complications in essential thrombocythemia. Ann Hematol. 2001, 80 (2): 74-8. 10.1007\/s002770000244.","journal-title":"Ann Hematol"},{"issue":"3","key":"105_CR13","first-page":"248","volume":"2","author":"T Barbui","year":"2003","unstructured":"Barbui T, Finazzi G: Treatment indications and choice of a platelet-lowering agent in essential thrombocythemia. Curr Hematol Rep. 2003, 2 (3): 248-56.","journal-title":"Curr Hematol Rep"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1749-8090-3-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1749-8090-3-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1749-8090-3-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1749-8090-3-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:49:22Z","timestamp":1630457362000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/1749-8090-3-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,30]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1186\/1749-8090-3-5","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,30]]},"assertion":[{"value":"20 August 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"5"}}